Search filters

List of works by Simonetta Viviani

A clinicopathologic study in advanced non-Hodgkin's lymphomas treated with sequential non-cross-resistant regimens: comparison of the working formulation with the Rappaport and Kiel classifications.

scientific article

ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term results

scientific article

Allogeneic transplantation improves the overall and progression-free survival of Hodgkin lymphoma patients relapsing after autologous transplantation: a retrospective study based on the time of HLA typing and donor availability

scientific article published on 10 March 2010

Alternating versus hybrid MOPP-ABVD in Hodgkin’s disease: The Milan experience ⬇️

scientific article published on February 1, 1991

Analysis of T Helper and Suppressor Lymphocyte Subsets in Relation to the Clinical Stage of Solid Neoplasms

article

BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens

scientific article published in December 2002

Bendamustine for Hodgkin lymphoma patients failing autologous or autologous and allogeneic stem cell transplantation: a retrospective study of the Fondazione Italiana Linfomi

scientific article published on 07 March 2014

Brentuximab vedotin in patients with Hodgkin lymphoma and a failed allogeneic stem cell transplantation: results from a named patient program at four Italian centers

scientific article

Brentuximab vedotin in relapsed/refractory Hodgkin's lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trials

scientific article published on 03 May 2013

CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease: associations with presenting features and clinical outcome

scientific article published in March 2002

Cytogenetic study in therapy-related myelodysplastic syndromes (t-MDS) and acute non-lymphocytic leukaemia (t-ANLL)

scientific article

Early Serum TARC Reduction Predicts Prognosis in Advanced-Stage Hodgkin Lymphoma Patients Treated with a PET-Adapted Strategy

scientific article published on 30 June 2020

Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses

scientific article published on 20 December 2010

Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study

scientific article published on 23 July 2007

Early stage Hodgkin's disease: Ten-year results of a non-randomised study with radiotherapy alone or combined with MOPP

scientific article published on 01 January 1992

Effect of an intensive chemotherapy followed by mediastinal irradiation on pulmonary and cardiac function in advanced Hodgkin's disease

scientific article published in April 2003

Elevated Serum Levels of IL-10 are Associated with Inferior Progression-Free Survival in Patients with Hodgkin's Disease Treated with Radiotherapy

scientific article published on 01 October 2004

Extended-field radiotherapy in favorable stage IA–IIA Hodgkin's disease (Prognostic role of stage)

scientific article published on 01 November 1994

Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse.

scientific article

Gonadal Damage in Hodgkin’s Disease from Cancer Chemotherapeutic Regimens

scientific article published on 01 January 1984

Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD

scientific article

Ifosfamide and vinorelbine: an active regimen for patients with relapsed or refractory Hodgkin's disease

scientific article published on 01 November 1998

Lack of carboplatin activity in malignant lymphomas

scientific article published on 01 December 1996

Late Pulmonary Effects in Favorable Stage I and IIA Hodgkin’s Disease Treated With Radiotherapy Alone

scientific article published on 01 February 2000

Late pulmonary toxicity after treatment for Hodgkin's disease

scientific article published on 01 November 1997

Long-Term Results of Autologous Hematopoietic Stem-Cell Transplantation After High-Dose 90Y-Ibritumomab Tiuxetan for Patients With Poor-Risk Non-Hodgkin Lymphoma Not Eligible for High-Dose BEAM.

scientific article published on 15 July 2013

Long-term results of high-dose chemotherapy with autologous bone marrow or peripheral stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin lymphoma: a single institution experience

scientific article published on 01 July 2010

Multiple defects of T helper cell function in newly diagnosed patients with Hodgkin's disease

scientific article published on 01 January 1994

Normalization of the light/dark rhythm of melatonin after prolonged subcutaneous administration of interleukin-2 in advanced small cell lung cancer patients

scientific article published in April 1992

Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases

scientific article

Prognostic Value of Bone Marrow Tracer Uptake Pattern in Baseline PET Scans in Hodgkin Lymphoma: Results from an International Collaborative Study.

scientific article published on 26 January 2017

Quality of life results from a phase 3 study of brentuximab vedotin consolidation following autologous haematopoietic stem cell transplant for persons with Hodgkin lymphoma

scientific article published on 21 September 2016

Radioimmunotherapy and secondary leukemia: a case report.

scientific article

Results of a randomized trial comparing high-dose chemotherapy plus Auto-SCT and R-FC in CLL at diagnosis.

scientific article published on 20 January 2014

Safety and efficacy of single-agent bendamustine after failure of brentuximab vedotin in patients with relapsed or refractory hodgkin's lymphoma: experience with 27 patients

scientific article published on 5 March 2015

Serum Thymus and Activation-Regulated Chemokine Level Monitoring May Predict Disease Relapse Detected by PET Scan after Reduced-Intensity Allogeneic Stem Cell Transplantation in Patients with Hodgkin Lymphoma

scientific article published on 23 August 2014

Serum level of the soluble form of the CD30 molecule identifies patients with Hodgkin's disease at high risk of unfavorable outcome ⬇️

scientific article published on April 15, 1998

Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications ⬇️

scientific article published on March 1, 1998

Survival in Hodgkin's disease patients--report of 25 years of experience at the Milan Cancer Institute

scientific article

Testicular dysfunction in Hodgkin's disease before and after treatment

scientific article published on January 1991

The biological significance of soluble interleukin-2 receptors in solid tumors

scientific article

The clinical significance of melatonin serum determination in oncological patients and its correlations with GH and PRL blood levels

scientific article published on 01 July 1987

The pathobiology and treatment of Hodgkin lymphoma. Where do we go from Gianni Bonadonna's lesson?

scientific article published on 22 February 2017

The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale

scientific article

Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis

scientific article published on 27 July 2006

Paulina is supported by:

About Paulina

Help